Transform Wealth LLC Trims Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Transform Wealth LLC decreased its position in The Procter & Gamble Company (NYSE:PGFree Report) by 2.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,212 shares of the company’s stock after selling 62 shares during the quarter. Transform Wealth LLC’s holdings in Procter & Gamble were worth $383,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Leisure Capital Management boosted its position in shares of Procter & Gamble by 0.5% in the 3rd quarter. Leisure Capital Management now owns 17,576 shares of the company’s stock worth $3,044,000 after purchasing an additional 91 shares in the last quarter. Sumitomo Life Insurance Co. boosted its holdings in Procter & Gamble by 3.1% in the third quarter. Sumitomo Life Insurance Co. now owns 69,377 shares of the company’s stock worth $12,016,000 after acquiring an additional 2,056 shares in the last quarter. Verum Partners LLC grew its stake in shares of Procter & Gamble by 1.4% in the third quarter. Verum Partners LLC now owns 6,324 shares of the company’s stock worth $1,095,000 after acquiring an additional 88 shares during the last quarter. Gleason Group Inc. increased its holdings in shares of Procter & Gamble by 0.6% during the third quarter. Gleason Group Inc. now owns 19,498 shares of the company’s stock valued at $3,377,000 after acquiring an additional 116 shares in the last quarter. Finally, Safeguard Financial LLC raised its position in shares of Procter & Gamble by 5.1% in the 3rd quarter. Safeguard Financial LLC now owns 7,268 shares of the company’s stock worth $1,259,000 after purchasing an additional 355 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Down 0.7 %

NYSE:PG opened at $172.36 on Thursday. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The business has a fifty day moving average price of $171.72 and a 200-day moving average price of $167.00. The firm has a market capitalization of $406.78 billion, a price-to-earnings ratio of 28.16, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. The business had revenue of $20.53 billion during the quarter, compared to analysts’ expectations of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business’s quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.37 earnings per share. Sell-side analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.34%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.69%.

Insider Activity

In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of the stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the completion of the sale, the insider now owns 13,072 shares in the company, valued at approximately $2,212,043.84. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, insider Susan Street Whaley sold 450 shares of the company’s stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the completion of the transaction, the insider now owns 13,072 shares of the company’s stock, valued at $2,212,043.84. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 383,194 shares of company stock worth $65,140,718 in the last three months. Company insiders own 0.17% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on PG shares. DZ Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a research note on Thursday, August 29th. Citigroup raised their price target on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and cut their target price for the company from $182.00 to $175.00 in a research note on Wednesday, July 24th. Royal Bank of Canada lifted their target price on Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a report on Wednesday, July 31st. Finally, Stifel Nicolaus increased their price objective on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research report on Monday, July 22nd. Nine research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $176.21.

View Our Latest Research Report on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.